drug safety

Pharma

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.

Angus Liu May 22, 2026 8:53am

Japan Japan pharma Japanese pharma Japan biopharma

Tavneos patient starts resume in Japan amid safety scrutiny

May 21, 2026 11:38am

Sun recalls chemotherapy lot in US after particle concerns

May 14, 2026 8:35am

Teva, Viatris launch separate recalls in the US

Apr 16, 2026 2:51pm

Lilly answers FDA's call for more Foundayo safety information

Apr 16, 2026 9:43am

Lilly told to gather more safety info on obesity launch Foundayo

Apr 14, 2026 4:08pm